Javascript must be enabled to continue!
Patological changes in cardiovascular system among the patients with post-COVID-19 syndrome
View through CrossRef
Currently, there is more and more data on the possible long-term effects of the new coronavirus infection (COVID-19) on human health. In particular, there is an increased risk of complications from the cardiovascular system in patients with post-COVID-19 syndrome. A review of the literature data on the most common cardiovascular complications of post-COVID-19 syndrome, the main pathogenetic mechanisms of these diseases and some recommendations for their prevention and treatment is presented. Aim. Analysis of scientific literature data on the role of SARS-CoV-2 infection and post-COVID-19 syndrome in the development of cardiovascular pathology. Key points. Cardiovascular pathology in patients with COVID-19 is a factor that seriously aggravates the course of the disease. At the same time, coronavirus infection itself can lead to cardiovascular complications, including in the framework of the post-COVID-19 syndrome. Among the main pathogenetic mechanisms of the development of cardiovascular complications are: dysregulation of the renin-angiotensin-aldosterone system (RAAS), direct cytotoxic effect of SARS-CoV-2 on cardiomyocytes, hypercytokinemia (cytokine storm). Anticoagulants (low molecular weight heparin), antihypertensive drugs (RAAS inhibitors), and inotropic agents are recommended as therapeutic tactics in the treatment of cardiovascular complications. If necessary, mechanical stimulation of blood circulation (extracorporeal membrane oxygenation), correction of electrolyte balance and suppression of excessive formation of catecholamines are indicated. Conclusion. Coronavirus infection can lead to the development of various cardiovascular complications, including fatal ones. In order to prevent pathological changes associated with coronavirus infection, monitoring of the morphofunctional state of the cardiovascular system of patients is necessary. Key words: COVID-19, SARS-СoV-2, post-COVID-19 syndrome, diseases of the cardiovascular system, cardiovascular patology.
NP Rusmedical Group
Title: Patological changes in cardiovascular system among the patients with post-COVID-19 syndrome
Description:
Currently, there is more and more data on the possible long-term effects of the new coronavirus infection (COVID-19) on human health.
In particular, there is an increased risk of complications from the cardiovascular system in patients with post-COVID-19 syndrome.
A review of the literature data on the most common cardiovascular complications of post-COVID-19 syndrome, the main pathogenetic mechanisms of these diseases and some recommendations for their prevention and treatment is presented.
Aim.
Analysis of scientific literature data on the role of SARS-CoV-2 infection and post-COVID-19 syndrome in the development of cardiovascular pathology.
Key points.
Cardiovascular pathology in patients with COVID-19 is a factor that seriously aggravates the course of the disease.
At the same time, coronavirus infection itself can lead to cardiovascular complications, including in the framework of the post-COVID-19 syndrome.
Among the main pathogenetic mechanisms of the development of cardiovascular complications are: dysregulation of the renin-angiotensin-aldosterone system (RAAS), direct cytotoxic effect of SARS-CoV-2 on cardiomyocytes, hypercytokinemia (cytokine storm).
Anticoagulants (low molecular weight heparin), antihypertensive drugs (RAAS inhibitors), and inotropic agents are recommended as therapeutic tactics in the treatment of cardiovascular complications.
If necessary, mechanical stimulation of blood circulation (extracorporeal membrane oxygenation), correction of electrolyte balance and suppression of excessive formation of catecholamines are indicated.
Conclusion.
Coronavirus infection can lead to the development of various cardiovascular complications, including fatal ones.
In order to prevent pathological changes associated with coronavirus infection, monitoring of the morphofunctional state of the cardiovascular system of patients is necessary.
Key words: COVID-19, SARS-СoV-2, post-COVID-19 syndrome, diseases of the cardiovascular system, cardiovascular patology.
Related Results
Differential Diagnosis of Neurogenic Thoracic Outlet Syndrome: A Review
Differential Diagnosis of Neurogenic Thoracic Outlet Syndrome: A Review
Abstract
Thoracic outlet syndrome (TOS) is a complex and often overlooked condition caused by the compression of neurovascular structures as they pass through the thoracic outlet. ...
Clinical manifestations of post-COVID-19 syndrome
Clinical manifestations of post-COVID-19 syndrome
Aim: to assess the prevalence of various clinical manifestations in COVID-19 survivors, depending on the time interval after the disease, clinical severity, and the presence of pol...
Three in One: Systemic Lupus Erythematosus, HELLP Syndrome, and Antiphospholipid Syndrome: A Case Report and Literature Review
Three in One: Systemic Lupus Erythematosus, HELLP Syndrome, and Antiphospholipid Syndrome: A Case Report and Literature Review
Abstract
Introduction
Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease commonly affecting women of reproductive age. Its overlap with HELLP syndrome (Hemolysi...
Apport de la TDM thoracique pour le dépistage de la COVID-19 et impact médico-économique de la pandémie à COVID-19 au service de radiologie de Fann (Dakar-Sénégal)
Apport de la TDM thoracique pour le dépistage de la COVID-19 et impact médico-économique de la pandémie à COVID-19 au service de radiologie de Fann (Dakar-Sénégal)
Objectives: To evaluate the contribution of thoracic CT in the diagnosis of patients suspected of having COVID-19 in comparison with the reference technique (RT-PCR) and to determi...
Septal panniculitis as manifestation of COVID-19: own data
Septal panniculitis as manifestation of COVID-19: own data
Objective: to study the clinical and laboratory features of erythema nodosum (EN) in a cohort of patients with COVID-19 referred to a rheumatological center.Patients and methods. D...
COVID-19 PANDEMIC AND MANAGEMENT OF HYPERTENSION
COVID-19 PANDEMIC AND MANAGEMENT OF HYPERTENSION
Dear Editor,
In December 2019, a new virus which is known as SARS-COV-2 (COVID-19) was identified. In a short period, this virus spread rapidly and caused significant morbidities a...
Using Primary Care Text Data and Natural Language Processing to Monitor COVID-19 in Toronto, Canada
Using Primary Care Text Data and Natural Language Processing to Monitor COVID-19 in Toronto, Canada
AbstractObjectiveTo investigate whether a rule-based natural language processing (NLP) system, applied to primary care clinical text data, can be used to monitor COVID-19 viral act...
The definition and risks of Cytokine Release Syndrome-Like in 11 COVID-19-Infected Pneumonia critically ill patients: Disease Characteristics and Retrospective Analysis
The definition and risks of Cytokine Release Syndrome-Like in 11 COVID-19-Infected Pneumonia critically ill patients: Disease Characteristics and Retrospective Analysis
IMPORTANCECOVID-19-infected pneumonia patients with severe immune abnormalities and risk of cytokine release syndrome. The definition, prevention, and treatment of COVID-19-infecte...

